1. Prognostic Role of IL-18 in Various Human Cancers and Radiation Injuries: A Meta-Analysis.
- Author
-
Yao, Zhen, Zhao, Minyan, Gao, Guangyu, Yang, Jiawen, Wang, Zhenzhen, and Liu, Yulong
- Subjects
- *
RADIATION injuries , *RADIATION carcinogenesis , *CANCER , *META-analysis , *BREAST cancer prognosis , *STOMACH cancer , *CANCER prognosis - Abstract
Background: In recent years, more and more studies have shown that various inflammatory factors have predictive effects on the prognosis of various human tumors. However, the prognostic role of interleukin 18 (IL-18) remains controversial. Furthermore, its role in radiation-induced injuries relating to radiotherapy (RT) is also unclear. In this study, we conducted the meta-analysis to clarify its roles in prognosis of human tumors and radiation-induced injuries relating to RT. Methods: We comprehensively searched PubMed, Embase, and Cochrane Library to identify studies published before November 2019 involving patients with cancer expressing IL-18 and which reported overall survival (OS) during the follow-up period. Results: A total of 1376 samples from 16 studies showed that high expression of IL-18 is closely related to prognosis and OS for patients with carcinoma (hazard ratio [HR]: 2.12; 95% CI: 1.81-2.49; P =.04; random-effect model). In addition, subgroup analysis proved that high expression of IL-18 was related to poor OS of hematologic tumor (HR: 2.03, 95% CI: 1.44-2.86, P <.00001), hepatocellular carcinoma (HR: 1.99, 95% CI: 1.38-2.86, P =.0002), and gastric cancer (HR: 2.00, 95% CI: 1.12-3.57, P =.02). Conclusions: High expression of IL-18 is related with poor prognosis of carcinoma. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF